Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) (UGP) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share)Trade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) trades at $7.63 (market cap $8.29B). The key difference: Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) is far larger — about 4.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) pays a 4.82% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) for 0 Days on average.

NUVBUGP
Market Cap
$1.74B$8.29B
Volume
9,289,6194,931,275
Sector
HealthEnergy
52-Week High
$9.54$7.79
52-Week Low
$3.41$3.63
Typical Hold Time
0 Days0 Days
Enterprise Value
$1.33B$10.34B
Dividend Yield
—4.82%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUVB
100% Buy0% Sell
Avg holding period · 0 Days
UGP
100% Buy0% Sell
Avg holding period · 0 Days

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share)

Ultrapar is a Brazilian company with fuel distribution, liquefied petroleum gas, and chemical businesses. Its consumer-facing operations include fuel and gas distribution brands.

Read more on UGP →